A few companies are in clinicals with novel approaches to heal an initial brain injury or minimize secondary damage. Slow progress may be more related to investors’ misperceptions of the topic than ...

Innovative designs of GPCRs with enhanced signaling and stability offer new insights for drug discovery and synthetic biology ...

A study reveals DNA and RNA epigenetics work together as a complementary system for precise gene regulation, crucial for cell ...

Tech titan Elon Musk announced Monday that the General Services Administration’s tech arm, 18F, has been “deleted,” appearing ...

Cultivated protein firm Umami Bioworks has expanded its capabilities and is aiming to tackle industry-wide challenges in the ...

From Warren Buffett and Bill Gates to newcomer Reed Hastings of Netflix, the most generous people in the country have doled ...

Understanding how tumors change their metabolism to resist treatments is a growing focus in cancer research. As cancer cells adapt to therapies, their metabolism often shifts, which can help them ...

Horizon Kinetics have published their Q4 2024 Commentary. How’d we do? How’d the market do? What to expect now? Click here to ...

Zibelli has managed this strategy since May 2006 and has managed Invesco Discovery Mid Cap Growth since June 2007. Before that, he was at Merrill Lynch, where he was leader of the small-growth team.